Press Release| Investors | Medtronic

Press Release

Printer Friendly Version View printer-friendly version
Download PDF Download PDF
<< Back
Medtronic EVP & CFO Karen L. Parkhill to Speak at Morgan Stanley Global Healthcare Conference

(GLOBE NEWSWIRE via COMTEX) --DUBLIN - September 4, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the Morgan Stanley 16th Annual Global Healthcare Conference on Friday, September 14, 2018, in New York City.

Karen Parkhill, executive vice president and chief financial officer of Medtronic, will answer questions about the company beginning at 10:30 a.m. EDT (9:30 a.m. CDT).

A live audio webcast of the session will be available on September 14, 2018, by clicking on the Investors Events link at http://investorrelations.medtronic.com. An archived audio file will be available for replay on the same webpage later in the day.

About Medtronic

Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end-

Contacts:

Fernando Vivanco

Public Relations

+1-763-505-3780

Ryan Weispfenning

Investor Relations

+1-763-505-4626

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Medtronic plc via Globenewswire

X